In the previous trading session, Indian benchmark indices traded cautiously as investors assessed quarterly earnings, corporate announcements and broader market sentiment.
Market participants will continue tracking earnings reports, strategic business developments, investments and regulatory updates that could influence stock-specific movements during today's trading session.
Bandhan Bank reported a strong first-quarter performance with net profit rising 35% year-on-year to ₹501.7 crore from ₹372 crore. Net interest income increased 5.9% to ₹2,920.6 crore, while provisions and contingencies declined 40.5% to ₹682.6 crore. Gross NPA improved to 3.15% from 3.27% quarter-on-quarter, while net NPA fell to 0.93% from 0.97%.
Indian Hotels Company posted a healthy quarterly performance, with consolidated net profit increasing 20.8% year-on-year to ₹357.9 crore. Revenue grew 14.6% to ₹2,339.2 crore, supported by continued strength in hospitality demand.
Mastek reported a 15% year-on-year rise in consolidated net profit to ₹105.9 crore. Revenue increased 7.7% to ₹985.3 crore, reflecting steady growth in the company's technology services business.
Cyient DLM delivered robust quarterly results as consolidated net profit more than doubled to ₹16.3 crore compared to ₹7.5 crore a year ago. Revenue climbed 34.3% to ₹373.8 crore, indicating strong business momentum.
Gabriel India reported a 2% increase in consolidated net profit to ₹107.4 crore, while revenue rose 15.5% to ₹1,425.7 crore. The company also announced the acquisition of a 30% stake in HL Klemove India for $98.44 million from HL Klemove Corporation, strengthening its automotive technology portfolio.
Maruti Suzuki announced a price increase of up to ₹30,000 across its vehicle portfolio due to rising input costs. The revised prices will come into effect from August 2026.
Anant Raj's Board approved a Composite Scheme of Arrangement aimed at restructuring the business into two focused listed entities. Subject to approval from the National Company Law Tribunal (NCLT), the company's fast-growing data centre and cloud services business will be separated from its real estate and infrastructure operations.
Read More: India Crude Oil Import Bill Jumps 61% to $49.8 Billion in Q1 Despite Lower Import Volumes!
Aurobindo Pharma's subsidiary, CuraTeQ Biologics, received approval from Brazil's National Health Surveillance Agency (ANVISA) for its biosimilars manufacturing facility in Hyderabad. The approval followed the successful completion of a Good Manufacturing Practice (GMP) inspection conducted in May 2026, enhancing the company's international manufacturing capabilities.
Aditya Birla Capital invested ₹123.89 crore through a rights issue in its associate, Aditya Birla Health Insurance Company. The investment will not alter the company's shareholding percentage, and the insurer will continue to remain an associate entity.
Several companies are scheduled to announce their quarterly earnings today, including Dr Reddy's Laboratories, Nestle India, Eternal, IndusInd Bank, CSB Bank, Adani Green Energy, Adani Power, Bharat Petroleum Corporation, Hindustan Petroleum Corporation, JSW Energy, Tata Communications, UCO Bank, United Spirits, UTI Asset Management Company and Waaree Renewable Technologies. Their results are likely to remain closely watched by investors.
Foreign portfolio investor Nova Vida acquired 7 lakh shares, representing a 0.66% stake in Bliss GVS Pharma, at ₹485 per share. The transaction was valued at approximately ₹33.95 crore.
Ved Investments purchased 3.55 lakh shares, representing a 0.7% stake in Manba Finance, at ₹138 per share. The deal was valued at around ₹4.9 crore.
Quarterly earnings, strategic restructuring, regulatory approvals, acquisitions and corporate investments are expected to drive stock-specific action in today's trading session, with investors closely monitoring these developments for potential market impact.
Want to track these market movements in Hindi? Visit Angel One News for daily updates and comprehensive share market news in Hindi.
Disclaimer: This blog has been written exclusively for educational purposes. The securities mentioned are only examples and not recommendations. This does not constitute a personal recommendation or investment advice. It does not aim to influence any individual or entity to make investment decisions. Recipients should conduct their own research and assessments to form an independent opinion about investment decisions.
Investments in the securities market are subject to market risks. Read all related documents carefully before investing.
Published on: Jul 22, 2026, 7:24 AM IST
Team Angel One
We're Live on WhatsApp! Join our channel for market insights & updates
Get the link to download the App
EN